Tag

Amgen’s Xgeva gets US FDA approval to treat hypercalcemia of malignancy refractory to bisphosphonate therapy

Upskill Your Pharma Knowledge

Explore Next Gen Learning

Case Studies & Caselets | Simulation Based Learning | E-Lectures | Online Self Competency Assessments

Thank You for Subscription!